IL6 and plasma cell myeloma: In SCID mice bearing U266, BABL/c bearing MPC-11, or murine myeloma xenograft models, the antitumor activity of ISL has also be found by ISL alone or in combination with Adriamycin via blocking IL-6 signaling [105].